Population
10 pentobarbitalized dogs
Design
Preclinical
Authors
Loading...
Animal findings indicate organ-specific flow preservation via reduced vascular hindrance; leaves open applicability to clinical hyperviscosity states.
Dextran-induced hyperviscosity leads to compensatory vasodilation in several vital organs, serving to maintain blood flow and nutrient transport.
Chen et al. (1989) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: